Anti-metastasis therapy: MiRNA-9600 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 18/November/2015, 11.41 pm

Anti-metastasis therapy: MiRNA-9600 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 18/November/2015, 11.41 pm

Anti-metastasis therapy: MiRNA-9600 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 18/November/2015, 11.41 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Research findings to Therapeutic opportunity: 

price-5

The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of TPM1 (tropomyosin). Thereby, it may inhibit migration and invasion of metastatic cancer cells. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit the progression of invasive tumors.

Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed information: How MiRNA-9600  increases the expression of metastasis suppressor TPM1

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

References: 

Citation: Boominathan, L., Anti-metastasis therapy: MiRNA-9600 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 18/November/2015, 11.41 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Anti-telomerase cancer therapy: MiRNA-149 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 18/November/2016, 11.14 am
Natural product-based PD-1 pathway blockade for Human cancer therapy: Eriocitrin, found in lemons , decreases the expression of Glycogen synthase kinase-3β, increases transcription factor T-bet expression, decreases the abundance of co-inhibitory receptor PD-1 on the cell surface of Cytotoxic-T-cells, increases cytotoxic T lymphocyte function and augments anti-tumor activity, via up-regulation of its target gene, 12.58 pm
Start Typing